FDA expanded use of Prevnar 13 vaccine to include people ages 50 and older
On Dec. 30, 2011, Pfizer announced that the U.S. Food and Drug Administration (FDA) had granted approval of…
Biotechnology | Diagnostics | Infectious Disease | Life Science News | NIH | Non-Profit Research | Vaccine
ACIP recommended all 11 to 12 year-old males get vaccinated against HPV
On Oct. 25, 2011, the Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP)…
Institute of Medicine issued the report titled “Review of Adverse Effects of Vaccines”
On Aug. 25, 2011, the Institute of Medicine issued the report titled “Review of Adverse Effects of Vaccines.”…
Sanofi Pasteur opened a $101 million vaccine research and development facility at Connaught Campus in Toronto
On Jun. 22, 2011, Sanofi Pasteur opened a $101 million dollar vaccine research and development facility at Sanofi…
Biotechnology | CDC | Diagnostics | Infectious Disease | Influenza | Life Science News | USDA | Vaccine
Novel Reassortant Highly Pathogenic Avian Influenza (H5N5) Viruses in Domestic Ducks, China
On Jun. 11, 2011, scientists in China reported the isolation of 2 novel reassortant highly pathogenic avian influenza…
CDC hailed vaccinations as one of 10 public health achievements of first decade of 21st century
On May 20, 2011, the U.S. Centers for Disease Control and Prevention (CDC) hailed vaccinations as one of…
FDA approved the first vaccine to prevent meningococcal disease in infants and toddlers
On Apr. 22, 2011, The U.S. Food and Drug Administration (FDA) approved the use of Menactra in children…
The first preventative vaccine for HIV was developed at University of Western Ontario
On Dec. 20, 2011, the U.S. Food and Drug Administration (FDA) announced approval of the first and only…
Biotechnology | Infectious Disease | Life Science News | Non-Profit Research | U.S. Congress | Vaccine
First smallpox vaccine for certain immune-compromised populations delivered under Project BioShield
On Jul. 13, 2010, Bavarian Nordic announced that it had delivered 1 million doses of its smallpox vaccine…
FDA recommended physicians suspend use of GSK’s Rotarix rotavirus vaccine due to porcine circovirus 1 contamination
On Mar. 23, 2010, the U.S. Food and Drug Administration (FDA) recommended that physicians temporarily suspend use of…
ACIP recommended use of a reduced (4-dose) vaccine schedule for PEP to prevent human rabies
On Mar. 19, 2010, the Immunization Practices Advisory Committee (ACIP) recommended use of a reduced (4-dose) vaccine schedule…
FDA approved licensure of Pneumococcal 13-valent conjugate vaccine
On Feb. 24, 2010, a 13-valent pneumococcal conjugate vaccine (PCV13 [Prevnar 13, Wyeth Pharmaceuticals, a subsidiary of Pfizer])…
ACIP recommended universal Influenza vaccination for those 6 months of age and older
On Feb. 24, 2010, the Immunization Practices Advisory Committee (ACIP) recommended universal Influenza vaccination for those 6 months…
FDA approved licensure of Menveo (Novartis), meningococcal conjugate vaccine
On Feb. 19, 2010, the U.S. Food and Drug Administration (FDA) announced it had licensed a quadrivalent meningococcal…
Biotechnology | Infectious Disease | Influenza | Life Science News | Non-Profit Research | Vaccine | WHO
Bill and Melinda Gates Foundation Pledged $10 Billion in Call for Decade of Vaccines
On Jan. 29, 2010, the Bill and Melinda Gates announced that their foundation will commit $10 billion over…
Thai HIV vaccine clinical trial results were published in the New England Journal of Medicine
On Dec. 3, 2009, the Thai HIV vaccine clinical trial results were published in the New England Journal…
Global Coalition against Child Pneumonia held first World Pneumonia Day
On Nov. 12, 2009, the Global Coalition against Child Pneumonia was established to raise awareness about the toll…
Merck announced the company will cease production of monovalent measles, mumps and rubella vaccines
On Oct. 21, 2009, Merck announced that the company will not resume production of monovalent measles, mumps, and…
FDA approved Cervarix, GlaxoSmithKline’s cervical cancer vaccine
On Oct. 16, 2009, GlaxoSmithKline announced the U.S. Food and Drug Administration (FDA) had approved Cervarix [Human papillomavirus…
Phase III results for first HIV/AIDS (Aidsvax) vaccine reported
On Sept. 24, 2009, the second Phase III HIV-1 vaccine trial, also known as RV144, that began in…
HHS announced advanced development contract for new way to make flu vaccine
On Jun. 23, 2009, the U.S. Department of Health and Human Services (HHS) announced advanced development contract for…
HHS directed $1 billion toward development of vaccine for novel influenza A (H1N1)
On May 22, 2009, the U.S. Dept. of Health and Human Services (HHS) directed $1 billion toward development…
Biotechnology | Infectious Disease | Life Science News | Medicine | Non-Profit Research | Therapeutics | Vaccine
OHSU, University of Washington scientists partner to form regional center aimed at combating infectious diseases
On Apr. 15, 2009, Oregon Health & Science University (OHSU) and the University of Washington (UW), along with…
ACIP voted to recommend hepatitis A vaccination for close contacts of international adoptees
On Feb. 25, 2009, the Advisory Committee on Immunization Practices (ACIP) recommended routine hepatitis A vaccination for household…
Vaccine Court ruled that MMR vaccine does not cause autism
On Feb. 12, 2009, the Vaccine Court ruled that MMR vaccine, when administered with thimerosal-containing vaccines, does not…
HHS awarded a $487 million contract to Novartis to build a facility to manufacture cell-based influenza vaccine
On Jan. 15, 2009, the U.S. Dept. of Health and Human Services (HHS) awarded Novartis a $487 million…
An increased risk of narcolepsy was found following vaccination with Pandemrix
In 2009, an increased risk of narcolepsy (a chronic sleep disorder) was found following vaccination with Pandemrix, a…
Drs. Judith James and Linda Thompson at the OMRF helped develop a H1N1 or ‘swine flu’ vaccine
In 2009, Drs. Judith James and Linda Thompson at the Oklahoma Medical Research Foundation (OMRF) helped develop an…
FDA approved changes in the schedule for administering anthrax vaccine
On Dec. 19, 2008, the Food and Drug Administration (FDA) approved changes in the schedule for administering anthrax…
FDA approved expanded indication for use of Boostrix Tdap vaccine in people ages 10-64 years
On Dec. 4, 2008, the Food and Drug Administration (FDA) approved an expanded age indication for the tetanus…